为整顿贪污受贿,中国将公布医疗腐败黑名单
2013年,随着针对奶粉公司和包括葛兰素史克公司 (GSK)等国内外药品公司的调查,医疗腐败成为中国的一个新闻焦点。中国政府誓将提高食品安全检查,并取缔药品的低质量生产销售、医疗器械的不法生产销售和化妆品中的非法使用违禁药品。 Read More
2013年,随着针对奶粉公司和包括葛兰素史克公司 (GSK)等国内外药品公司的调查,医疗腐败成为中国的一个新闻焦点。中国政府誓将提高食品安全检查,并取缔药品的低质量生产销售、医疗器械的不法生产销售和化妆品中的非法使用违禁药品。 Read More
On December 17, 2013, the China Food and Drug Administration (CFDA) announced a streamlined device registration renewal process that took effect on January 1. The updated process will reduce the burden of paperwork on manufacturers, result in faster renewal certification approvals and... Read More
Healthcare corruption in China was a big news item in 2013, with investigations conducted into milk powder firms as well as both domestic and international drug companies, such as GlaxoSmithKline (GSK). Chinese authorities have vowed to increase food product safety checks and... Read More
重组后的中国国家食品药品监督管理总局(CFDA)将加大对于医疗器械上市后的监管力度。其中的改变包括对不良事件报告的处理以及医疗器械重新注册。这两项程序将在2014和2015年经历重大改变。 Read More
由于今年北京、哈尔滨及新近的上海出现严重雾霾,口罩及手术口罩在中国的销量迅猛增长。2013年12月,杭州和上海的空气污染程度超过世界卫生组织标准四十多倍。据上海城市卫生局所公布的数据显示,仅过去的几天,上海市由于呼吸道问题入院的病人数量提升了30%。 Read More
As China's Food and Drug Administration (CFDA) undergoes reorganization, it is placing more emphasis on post-market compliance for medical devices. This includes changes to processes such as Adverse Events (AE) reporting and the re-registration of medical devices. Both of these processes will... Read More
The sale of respirators and surgical masks is skyrocketing in China, which has been plagued this year by severe smog incidents in Beijing, Harbin and most recently Shanghai. In December 2013, air pollution levels surpassed World Health Organization standards by more than... Read More
China’s pharmaceutical market is booming! The market is growing almost 15% annually and is expected to be about $100 billion dollars in 2017. However, drug regulations are complicated in China. In addition, once your drug is approved, what needs to be done... Read More
According to a November report, China’s $1 billion X-ray market is set to reach $1.6 billion by 2017. At that time, China will account for more than 20 percent of global general radiography revenues, which will be equivalent to the combined general... Read More
With the mid-November release of a major government economic reform plan, foreign medical device, pharmaceutical and healthcare firms doing business in China are anticipating widespread changes to investment regulation and market access in China. In particular, healthcare insurance companies and hospital management... Read More